ストックスクリーナーアプリを入手
0.5164
2.07%
-0.0109
前日終値:
$0.5273
開ける：
$0.52
24時間の取引高:
73,058
Relative Volume:
0.42
時価総額：
$26.98M
収益：
$30.31M
当期純損益:
$-22.84M
株価収益率:
-1.1476
EPS:
-0.45
ネットキャッシュフロー:
$-22.61M
1週間 パフォーマンス:
-5.27%
1か月 パフォーマンス:
-23.55%
6か月 パフォーマンス:
-53.48%
1年 パフォーマンス:
-61.17%
1日の値動き範囲:
$0.505
$0.5286
1週間の範囲:
$0.46
$0.56
52週間の値動き範囲:
$0.4122
$1.40
Enzo Biochem Inc Stock (ENZ) Company Profile
ENZ を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENZ
Enzo Biochem Inc
|
0.5164 | 26.98M | 30.31M | -22.84M | -22.61M | -0.45 |
|
TMO
Thermo Fisher Scientific Inc
|
532.55 | 203.70B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.23 | 151.18B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
135.37 | 38.62B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
452.77 | 37.07B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
191.04 | 33.64B | 15.41B | 1.37B | 2.11B | 7.50 |
Enzo Biochem Inc Stock (ENZ) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2011-10-18 | 繰り返されました | Rodman & Renshaw | Mkt Outperform |
| 2009-09-23 | 開始されました | Rodman & Renshaw | Mkt Outperform |
| 2007-09-13 | 開始されました | Lazard Capital | Buy |
Enzo Biochem Inc (ENZ) 最新ニュース
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - Defense World
Enzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.com - Defense World
Enzo Biochem, Inc.'s (NYSE:ENZ) 28% Share Price Plunge Could Signal Some Risk - Simply Wall St
Enzo Biochem stock hits 52-week low at $0.51 amid challenges - MSN
ENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024 - MSN
StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Neuroscience Antibodies and Assays Market to Grow by USD 2.20 Billion from 2024-2028, Rising Neurological Disorders Boost Growth, Report on How AI is Redefining Market LandscapeTechnavio - The Malaysian Reserve
StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem stock hits 52-week low at $0.63 amid market challenges - Investing.com Canada
Enzo Biochem stock hits 52-week low at $0.63 amid market challenges By Investing.com - Investing.com South Africa
Enzo Biochem settles class action for $7.5 million - MSN
Enzo Biochem settles class action for $7.5 million By Investing.com - Investing.com Australia
Enzo Biochem shareholders elect board, approve executive pay - Investing.com India
Enzo Biochem shareholders elect board, approve executive pay By Investing.com - Investing.com UK
Enzo Biochem’s Strategy to Resolve NYSE Compliance Issues - Zenopa
Enzo Biochem Agrees to Settlement in Class Action Suit Related to Ransomware Attack - Defense World
Enzo Biochem to Pay $7.5 Million to Settle Suit Over 2023 Breach - Bloomberg Law
Enzo Biochem Receives Notice from NYSE Regarding Listing ComplianceFarmingdale, NY – Enzo Biochem, Inc. (NYSE: ENZ) recently disclosed that it received a notice from the New York Stock Exchange (NYSE) indicating non-compliance with certain listing - Defense World
Enzo Biochem faces NYSE compliance challenges By Investing.com - Investing.com Canada
Enzo Biochem faces NYSE compliance challenges - Investing.com
Enzo Biochem Faces NYSE Compliance Challenges - TipRanks
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules - The Manila Times
Enzo Biochem Receives NYSE Non-Compliance Notice Over Market Cap and Share Price Issues - StockTitan
ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand Challenges - MSN
Enzo Biochem (NYSE:ENZ) versus Grail (NASDAQ:GRAL) Financial Review - Defense World
Enzo Biochem stock hits 52-week low at $0.68 amid challenges - Investing.com Nigeria
Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com - Defense World
Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - Defense World
Enzo Biochem (ENZ) Stock Surges 5.19% Amid Market Activity - GuruFocus.com
Enzo Biochem Inc (ENZ) 財務データ
収益
当期純利益
現金流量
EPS
0.06%
3.50%
大文字化:
|
ボリューム (24 時間):